Back to Search
Start Over
CHMP recommends marketing approval for Sanofi's Sarclisa to treat relapsed and refractory MM
- Source :
- PharmaBiz. March 30, 2020
- Publication Year :
- 2020
-
Abstract
- The European Medicines AgencyÇÖs Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sarclisa (isatuximab). The CHMP recommends Sarclisa in combination with pomalidomide and dexamethasone [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.618945354